The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic Agent

Radiation therapy is a mainstay of treatment in early and locally advanced breast cancer but is typically reserved for palliation of symptomatic lesions in patients with metastatic breast cancer. With new advances in the feld of tumor biology and immunology, the role of radiation in the metastatic setting is evolving to harness its immune-enhancing properties. Trough the release of tumor antigens, tumor DNA, and cytokines into the tumor microenvironment, radiation augments the antitumoral immune response to afect both the targeted lesion and distant sites of metastatic disease. Te use of immunotherapeutics to promote antitumoral immunity has resulted in improved treatment responses in patients with metastatic disease and the combination of radiation therapy and immunotherapy has become an area of intense investigation. In this article, we will review the emerging role of radiation in the treatment of metastatic disease and discuss the current state of the science and clinical trials investigating the combination of radiation and immunotherapy.